ExcepGen
PrivateLast Round
Seed
Aug 24, 2023
Est. Valuation
$2.14M
Total Funding Raised
$4.15M
Company Overview
ExcepGen is a biotechnology company that is developing a platform for nucleic acid therapeutics designed to improve the efficacy and tolerability of DNA and RNA-based medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ExcepGen Comparables
Compare ExcepGen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Replicate Bioscience | 78% | |
| Kernalbio | 77% | |
| eTheRNA | 76% | |
ExcepGen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 24, 2023 | ||||
| Accelerator | Mar 15, 2019 |
ExcepGen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Seed |
| ZAKA VC | Seed |
| VitaDAO | Accelerator |
| Gravity Fund | Seed |
| Y Combinator | Accelerator |
| Gravity Fund | Seed |
| Apollo Projects | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2023
$4M round led by RA Capital Management
ExcepGen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ExcepGen's valuation, stock price, and market status.